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Complex cyanotic congenital heart diseases with left isomerism are sometimes associated with atrio-
ventricular nodal conduction disturbances that may need permanent pacing. Surgical palliation in such
anatomy connecting the superior vena cava to the pulmonary artery precludes a transvenous access for
an endocardial pacing lead to the ventricles. Epicardial leads in these patients fail if the pacing thresholds
are very high. We report transhepatic permanent ventricular lead implantation for a young boy with
heterotaxy complicated by complete heart block.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Certain complex cyanotic congenital heart diseases in the
setting of atrioventricular discordance, univentricular hearts and
left isomerism can be associated with atrioventricular nodal con-
duction disturbances [1]. Bradycardia in these patients may
adversely affect their precarious hemodynamics and often need
permanent pacemaker implantation [2]. Bradycardia in these pa-
tients may be diagnosed either at birth or at a later age in the
natural history of the disease. Surgical palliation in these complex
anatomy involves cavo pulmonary anastamosis (Bidirectional
Glenn shunt, Kawashima operation or Fontan surgery). Epicardial
lead placement by thoracotomy or sternotomy and placement of
pulse generator in the subrectus sheath in abdominal wall or in the
subpleural pocket within the thorax is the standard therapy as
transvenous ventricular lead placement is impossible after a cavo
pulmonary shunt. This epicardial lead insertion carries a risk of
higher pacing thresholds and need for more invasive surgery than a
transvenous endocardial pacing [3]. We report percutaneousiatric Cardiology, Institute of
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ociety. Production and hosting byplacement of pacing lead through hepatic vein in a patient with left
isomerism and complete heart block who underwent Kawashima
operation.
2. Case report
A seven years old Kenyan patient with oxygen saturations of 80%
was diagnosed with complex congenital heart disease. He had left
isomerism, azygos continuation of interrupted inferior vena cava,
common atrium, common atrioventricular valve, single ventricle,
severe valvar and supravalvar pulmonary stenosis. His preoperative
electrocardiogram showed wandering pacemaker, complete heart
block with ventricular rate of 45/minute (Fig. 1). Catheterization
hemodynamics showed acceptable pulmonary artery pressures and
pulmonary vascular resistance for univentricular palliation. His
preoperative hospital admission was complicated by suppurative
otitis media caused by pseudomonas aeruginosa, which was
treated by appropriate antibiotics.
He underwent Kawashima repair (surgical end to side anasta-
mosis of superior vena cava to right pulmonary artery without
ligation of the azygos vein which allows entire systemic venous
return to reach pulmonary circulationwith exception of the hepatic
venous return), main pulmonary artery ligation and temporary
epicardial ventricular pacing wire placement for pacing in the post
operative period.
A permanent pacing lead and pulse generator was notElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Electrocardiogram showing complete heart block, ventricular rate 45 per minute, narrow QRS complexes and wandering pacemaker.
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operative course in the intensive care, the ventricular pacing
thresholds in the temporary epicardial leads were very high (12 mA
in the constant voltage temporary pacemaker) and progressively
increased raising doubts about the suitability of permanent
epicardial pacing leads. An endocardial pacing lead placement was
actively considered since the epicardial thresholds were unac-
ceptable. In view of avoiding a second major surgery after recovery
from a recent ear infection, he was planned for a transhepatic
endocardial lead placement into the ventricles and connecting the
pacing lead to a permanent generator in the subrectus sheath in the
anterior abdominal wall. All antiplatelet and anticoagulant drugs
were withdrawn before the procedure. Since echocardiogram
showed good delineation of the hepatic veins, no additional
tomographic imaging were performed.
Under ultrasound guidance transhepatic access was obtained
through subxiphoid window through an appropriate hepatic vein
tributary that ﬁnally reached the atrium. The liver was in midline
and so both the right and left hepatic veins were converging to-
wards the atrium in the subxiphoid area. A 0.02500 short wire
passed through this access to atrium and a short 6french introducer
sheath was introduced into the atria. Even though a 7French
introducer was recommended for the lead, a smaller sheath was
chosen to give the lead a snug ﬁt around the liver parenchyma and
prevent a perilead bleeding. An endocardial screwing permanent
pacing leadwasmanipulated into the apex of the single ventricle by
shaping the stylet and lead tip was positioned to get appropriate
pacing parameters. Since the heart was univentricular, the ven-
tricular hypertrophy of the anterolateral wall had sufﬁcient wall
thickness for placing the screw-in lead and this reduced chances of
perforation. The lead resistance was 600 U and pacing threshold
was 0.4 V at a pulse width of 0.4 milliseconds. Once the lead tip was
secured in the apex of the ventricle, a sufﬁcient loop was added in
the atrium to allow for growth of the cardiac chambers. A surgical
pocket was created in the subrectus sheath and the pacing lead was
connected to the generator (Fig. 2 and 3). Post procedure ultra-
sonogram showed no evidence of any local liver injury, hematoma
or hepatic vein thrombosis. The child had a smooth post procedure
recovery and was discharged on sixth day after the procedure.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.ipej.2016.06.003.3. Discussion
Complete heart block is relatively common in certain forms of
complex cyanotic congenital heart diseases that often need cav-
opulmonary shunts as their palliation. In any patient who had
Glenn shunt, Kawashima shunt or Fontan surgery, epicardial per-
manent pacing is the usual standard of care. This often requires a
major surgical procedure involving thoracotomy or sternotomy and
is more morbid than a transvenous endocardial lead placement.
Such an epicardial pacing can be done with either screw-in uni-
polar leads or forked buttoned bipolar leads. When there are
ﬁbrotic scars on the epicardial surface due to previous surgical
adhesions, unipolar screw-in ventricular leads are often preferred
to bipolar buttoned leads. The major difﬁculties encountered in
epicardial leads include (i) need for thoracotomy or sternotomy in a
compromised cyanotic patient which requires intubation anes-
thesia (ii) surgical dissection through the adhesions from the pre-
vious cardiac surgeries (iii) higher pacing thresholds in epicardial
leads through the adhesion scars compared to endocardial leads
(iv) higher chances of diaphragmatic pacing in the unipolar leads
which are most often implanted during such epicardial placements.
Chronic epicardial lead performance has historically been inferior,
with higher pacing and lower sensing thresholds and earlier bat-
tery depletion rates than transvenous systems [4]. Higher lead
failure rates are also noted, with one report observing a 40% failure
rate of epicardial atrial leads within 5 years of implantation [5].
Transvenous access for any catheter or electrophysiology inter-
vention is challenging in patients after Fontan and Kawashima
surgeries where the catheters from jugular and femoral venous
access donot reach the cardiac chambers. As an alternative access,
transhepatic access has been tried for different transcatheter and
electrophysiology intervention [1,2]. Placement of permanent
pacing leads through hepatic veins in such instances were
considered in the past [1]. This access was found to be safe and
provided a viable alterative without any signiﬁcant major compli-
cation [2]. In patients with extracardiac conduit Fontan surgery
where a polytetraﬂuoro ethylene or dacron conduit bridges the
inferior vena cava to the pulmonary artery, a sharp pucture through
the conduit into the atriumwas made with a Brokenbrough needle
through transhepatic access to gain entry into the atrium followed
by placement of a permanent pacing lead [2].
Fig. 2. Panel A shows percutaneous venous access through the right hepatic vein into the atria using a 0.02500 guide wire; Panel B shows placement of a ventricular screw-in lead
with a redundant loop in the atrium to account for somatic growth of the child; Panel C shows connection of the pulse generator to the pacing lead after creation of a right subrectus
pocket; Panel D shows the lateral view of the lead coursing through the liver parenchyma from the subrectus pocket (Movie 1A, 1B, 1C, 1D).
Fig. 3. Chest X ray in anteroposterior projection after the procedure showing the pulse
generator and lead position in the ventricular apex. Features of left isomerism include
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active liver disease, liver abscess or peritonitis. In such patients,
direct puncture of the undersurface of the right pulmonary artery
that overlies the atrial mass through the Glenn circuit will give a
direct access to the atrium through the transverse sinus of the
heart, which is a potential space. Recently a transvenous pacing in a
patient after extracardiac conduit Fontan surgerywas done through
the subclavian route by placing a pacing lead from subclavian vein
to atrium through this route [6].
Awareness about the utility of transhepatic access for perma-
nent pacing in patients who donot have superior vena caval access
will expand the horizon for such patients. It may be considered in
patients who have high epicardial pacing thresholds too as a
brighter alternative option. We opted for a 6French introducer
sheath instead of the recommended 7French sheath to avoid leak of
blood through the anterior capsule of the liver parenchyma
following peeling of the sheath. Complications that might occur in
this approach include hepatic bleed into the peritoneum or in the
subcutaneous plane which may warrant drainage and transfusion
of blood products. This can be circumvented by careful ultrasound
guided puncture into the hepatic veins and ensuring optimal
coagulation parameters prior to the procedure. We avoided all
antiplatelet and anticoagulants prior to the procedure, and pre-
treated with vitamin K to improve the hepatic synthesis of coagu-
lation factors. Even though transient mild elevation of liver
enzymes is very rarely reported from the traumatic entry into the
liver, this is often clinically insigniﬁcant. Another concern is an
increased risk of systemic thromboembolism from a transvenousbilateral horizontal left sided bronchus, midline liver and right sided gastric shadow.
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relevant increase in such events after transvenous lead compared
to epicardial lead and aspirin and warfarin was not shown to be
protective [3].
4. Conclusion
Transhepatic permanent pacing lead placement in patients after
complex cyanotic heart disease palliations with Glenn shunt,
Kawashima shunt or Fontan surgery is a safe and feasible alterna-
tive to open surgical epicardial pacing lead placement in carefully
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